Availability of ulipristal acetate: A secret shopper survey of pharmacies in a metropolitan area on emergency contraception

被引:13
|
作者
French, Valerie A. [1 ]
Mattingly, Tateum L. [2 ]
Rangel, Ariana V. [2 ]
Shelton, Annie U. [3 ]
机构
[1] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66103 USA
[2] Univ Kansas, Sch Med, Kansas City, KS USA
[3] Univ Kansas Hlth Syst, Dept Pharm, Kansas City, KS USA
关键词
ACCESS; KNOWLEDGE; EFFICACY;
D O I
10.1016/j.japh.2019.06.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To assess levonorgestrel (LNG) and ulipristal acetate (UPA) availability in pharmacies in a metropolitan area. Methods: A cross-sectional survey was conducted of all identified pharmacies within 25 miles of an urban medical center in Kansas City, KS. We categorized the pharmacies as dedicated commercial (national chains), store-associated (affiliated with a general merchandise or grocery store), or independent. We assessed LNG and UPA availability or time to availability if not currently stocked. Results: We contacted 165 pharmacies. Of the 165 pharmacies, few stocked UPA (12/165, 7%) whereas the majority stocked oral LNG (128/165, 78%). Dedicated commercial pharmacies were more likely to carry UPA than store-associated and independent pharmacies (11/84 [13%] vs. 1/61 [1%] vs. 0/20, respectively; P = 0.016). Most pharmacies that did not stock UPA reported that they could obtain it within 24 hours (94/153, 62%). Dedicated commercial pharmacies were most likely report the ability to obtain UPA in 24 hours (P = 0.016). Conclusion: Few pharmacies stock UPA, the most effective form of oral emergency contraception. Enhanced communication between medical providers and pharmacists within current laws and regulations could enhance patient access to UPA. (C) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:832 / 835
页数:4
相关论文
共 50 条
  • [21] Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review
    Rosato, Elena
    Farris, Manuela
    Bastianelli, Carlo
    FRONTIERS IN PHARMACOLOGY, 2016, 6
  • [22] Emergency contraception supply in Australian pharmacies after the introduction of ulipristal acetate: a mystery shopping mixed-methods study
    Collins, Jack Charles
    Schneider, Carl Richard
    Moles, Rebekah Jane
    CONTRACEPTION, 2018, 98 (03) : 243 - 246
  • [23] Does ulipristal acetate emergency contraception (ella®) interfere with implantation?
    Li, Hang Wun Raymond
    Resche-Rigon, Michele
    Bagchi, Indrani C.
    Gemzell-Danielsson, Kristina
    Glasier, Anna
    CONTRACEPTION, 2019, 100 (05) : 386 - 390
  • [24] Availability of emergency contraception at rural and urban pharmacies in Pennsylvania
    Chuang, CH
    Shank, LD
    CONTRACEPTION, 2006, 73 (04) : 382 - 385
  • [25] Availability of Emergency Contraception in Rural and Urban Pharmacies in Kansas
    Samson, Fernand D.
    Loren, Rebecca
    Downing, Nicki
    Schroeppel, Sarah
    Kelly, Patricia J.
    Ramaswamy, Megha
    JOURNAL OF RURAL HEALTH, 2013, 29 (01): : 113 - 118
  • [26] Emergency Contraception Access and Counseling in Metropolitan and Nonmetropolitan Pharmacies in Georgia
    Stone, Rebecca H.
    Gross, Savannah
    Reardon, Brielle
    Young, Henry N.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 523 - 531
  • [27] Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception
    Jatlaoui, Tara C.
    Riley, Halley
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 93 (02) : 93 - 112
  • [28] Results from pooled Phase III studies of ulipristal acetate for emergency contraception
    Moreau, Caroline
    Trussell, James
    CONTRACEPTION, 2012, 86 (06) : 673 - 680
  • [29] Availability of Emergency Contraception in the Emergency Department: A National Survey
    Cowdery, C. P.
    Halloran, D.
    Elie, M-C
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S103 - S104
  • [30] RESULTS FROM POOLED PHASE III STUDIES OF ULIPRISTAL ACETATE FOR EMERGENCY CONTRACEPTION
    Moreau, C.
    Trussell, J.
    CONTRACEPTION, 2011, 84 (03) : 308 - 308